Quick Answer
NICE Ltd. reported Total Revenue of $2.95 billion for fiscal year 2025.
NICE Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.95B +7.7% |
$2.74B +15.0% |
$2.38B +9.0% |
$2.18B +13.5% |
$1.92B +16.6% |
$1.65B +4.7% |
| Net Income | $612.10M +39.3% |
$439.50M +30.6% |
$336.50M +26.9% |
$265.10M +32.8% |
$199.57M +1.5% |
$196.67M +5.8% |
| Diluted EPS | $9.67 +43.0% |
$6.76 +32.3% |
$5.11 +27.8% |
$4.00 +34.2% |
$2.98 +0.0% |
$2.98 +3.5% |
| Total Assets | $5.11B -3.6% |
$5.30B +3.5% |
$5.12B +5.4% |
$4.85B +3.1% |
$4.71B +11.3% |
$4.23B +17.3% |
| Cash and Equivalents | $379.39M -21.2% |
$481.71M -5.9% |
$511.80M -3.4% |
$529.60M +39.9% |
$378.66M -14.4% |
$442.27M +93.7% |
| Long-Term Debt | — | $0.00 -100.0% |
$457.08M +0.4% |
$455.38M +6.1% |
$429.27M +1.9% |
$421.34M +97.5% |
| Stockholders Equity | $3.88B +8.0% |
$3.59B +7.4% |
$3.34B +9.8% |
$3.04B +7.7% |
$2.83B +10.2% |
$2.56B +13.6% |
| R&D Expense | $360.45M -0.0% |
$360.61M +11.7% |
$322.71M +5.4% |
$306.07M +12.9% |
$271.19M +24.3% |
$218.18M +12.6% |
| Operating Income | $645.76M +18.3% |
$545.95M +25.4% |
$435.23M +29.9% |
$335.17M +27.0% |
$263.91M +9.0% |
$242.05M +1.4% |
| Gross Profit | $1.96B +7.1% |
$1.83B +13.4% |
$1.61B +7.5% |
$1.50B +15.5% |
$1.30B +19.4% |
$1.09B +4.2% |
| Shares Outstanding | 60.43M -4.5% |
63.25M +0.6% |
62.87M -1.2% |
63.63M +0.2% |
63.48M +0.7% |
63.05M +1.0% |
- NICE Ltd. reported Total Revenue of $2.95 billion for fiscal year 2025.
- NICE Ltd. showed an increase of +7.7% in Total Revenue compared to the prior fiscal year.
- NICE Ltd. reported Net Income of $612.10 million for fiscal year 2025.
- NICE Ltd. showed an increase of +39.3% in Net Income compared to the prior fiscal year.
- NICE Ltd. reported Diluted EPS of $9.67 per share for fiscal year 2025.
- NICE Ltd. showed an increase of +43.0% in Diluted EPS compared to the prior fiscal year.
- NICE Ltd. reported Total Assets of $5.11 billion for fiscal year 2025.
- NICE Ltd. showed a decrease of -3.6% in Total Assets compared to the prior fiscal year.
- NICE Ltd. reported Cash and Equivalents of $379.39 million for fiscal year 2025.
- NICE Ltd. showed a decrease of -21.2% in Cash and Equivalents compared to the prior fiscal year.
- NICE Ltd. reported Long-Term Debt of $0.00 for fiscal year 2024.
- NICE Ltd. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- NICE Ltd. reported Stockholders Equity of $3.88 billion for fiscal year 2025.
- NICE Ltd. showed an increase of +8.0% in Stockholders Equity compared to the prior fiscal year.
- NICE Ltd. reported R&D Expense of $360.45 million for fiscal year 2025.
- NICE Ltd. showed a decrease of -0.0% in R&D Expense compared to the prior fiscal year.
- NICE Ltd. reported Operating Income of $645.76 million for fiscal year 2025.
- NICE Ltd. showed an increase of +18.3% in Operating Income compared to the prior fiscal year.
- NICE Ltd. reported Gross Profit of $1.96 billion for fiscal year 2025.
- NICE Ltd. showed an increase of +7.1% in Gross Profit compared to the prior fiscal year.
- NICE Ltd. reported Shares Outstanding of 60.43 million shares for fiscal year 2025.
- NICE Ltd. showed a decrease of -4.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: